sunrise semaglutide TGA warns of suicide risk with weight loss drugs | 🌸New GLP-1 Pricing is here!

In Rybelsus (Novo Nordisk), Semaglutide forms a non-covalent linkage with N-[8-(2-hydroxybenzoyl)aminocaprylate] (SNAC), which protects the peptide from degradation by enzymes and acids and accelerates its targeted release and absorption in the stomach

F., Reid, J., Sheikh-Ali, M., Sutton, D., & Choksi, R

These medications promote greater insulin release from your pancreas after eating

These therapies, initially designed for type 2 diabetes, have demonstrated significant weight loss benefits, leading to their expanded use in obesity management

Diabetic patients on Ozempic experienced notable weight loss, which led Novo Nordisk to create a semaglutide for patients struggling with obesity

Interestingly, now that they have been removed from that list, a different access-related challenge may occur in that if compounding pharmacies are unable to supply these drugs (due to them no longer being on the FDA shortage list), individuals who obtained their medication via such methods may experience higher overall costs